Valentín García-Gutiérrez

32PUBLICATIONS
140CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyHaematologyRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Jul 13, 2026
Mutational profile and cardiovascular risk factors impact prognosis in triple-negative essential thrombocythemia.

|May 07, 2025
Asciminib remained superior vs bosutinib in late-line CML-CP after nearly 4 years of follow-up in ASCEMBL.

Michael J Mauro, Yosuke Minami, Andreas Hochhaus

|Dec 11, 2024
Ruxolitinib in acute and chronic graft-versus-host disease: real life long-term experience in a multi-center study for adult and pediatric patients, on behalf of the GETH-TC.

Virginia Escamilla-Gómez, Valentín García Gutiérrez, Patricia Alcalde-Mellado

|Sep 28, 2024
Prognostic value of response to first-line hydroxyurea according to IPSET stratification in essential thrombocythemia.

Marta Santaliestra, Marta Garrote, María Soledad Noya

|Aug 20, 2024
Efficacy and safety of bosutinib in previously treated patients with chronic myeloid leukemia: final results from the BYOND trial.

Carlo Gambacorti-Passerini, Tim H Brümmendorf, Elisabetta Abruzzese

|Feb 10, 2024
e14a2 Transcript Favors Treatment-Free Remission in Chronic Myeloid Leukemia When Associated with Longer Treatment with Tyrosine Kinase Inhibitors and Sustained Deep Molecular Response.

Sílvia Marcé, Aleix Méndez, Blanca Xicoy

Pageof 6

Frequent Collaborators

12 joint publications

Juan-Carlos Hernández-Boluda

8 joint publications

Beatriz Cuevas

7 joint publications

Alberto Álvarez-Larrán

7 joint publications

Gonzalo Carreño-Tarragona